CTOs on the Move

Cool Springs Psychiatric Group

www.cspsychiatric.com

 
Cool Springs Psychiatric Group is a Franklin, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Juvly

Juvly Aesthetics is the fastest growing aesthetics practice in the United States, expanding since 2014, from a single location in Columbus, Ohio to eleven locations across the United States! Our team has gone from servicing just 10 clients to over 53,000 in five short years! The core of this growth stems from our unique values, which include; providing fantastic, natural-beauty enhancing results, transparent prices, and excellent customer service. Whether you are a client looking for first class services, or an eager employment-seeker, Juvly is the place for you!

Ryan Brothers Ambulance

Ryan Brothers Ambulance is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Brooklyn United Methodist Church Home

Brooklyn United Methodist Church Home is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Brooklyn, NY. To find more information about Brooklyn United Methodist Church Home, please visit www.bumch.org

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

Vivascience

Vivascience is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.